124 related articles for article (PubMed ID: 22907801)
1. HER2 status of gastric carcinoma and corresponding lymph node metastasis.
Pagni F; Zannella S; Ronchi S; Garanzini C; Leone BE
Pathol Oncol Res; 2013 Jan; 19(1):103-9. PubMed ID: 22907801
[TBL] [Abstract][Full Text] [Related]
2. HER2 expression variability between primary gastric cancers and corresponding lymph node metastases.
Qiu Z; Sun W; Zhou C; Zhang J
Hepatogastroenterology; 2015; 62(137):231-3. PubMed ID: 25911901
[TBL] [Abstract][Full Text] [Related]
3. Is her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy?
Selcukbiricik F; Erdamar S; Buyukunal E; Serrdengecti S; Demirelli F
Asian Pac J Cancer Prev; 2014; 15(24):10607-11. PubMed ID: 25605147
[TBL] [Abstract][Full Text] [Related]
4. Differing deregulation of HER2 in primary gastric cancer and synchronous related metastatic lymph nodes.
Kochi M; Fujii M; Masuda S; Kanamori N; Mihara Y; Funada T; Tamegai H; Watanabe M; Suda H; Takayama T
Diagn Pathol; 2013 Nov; 8():191. PubMed ID: 24261710
[TBL] [Abstract][Full Text] [Related]
5. Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.
Fleischmann A; Rotzer D; Seiler R; Studer UE; Thalmann GN
Eur Urol; 2011 Aug; 60(2):350-7. PubMed ID: 21640482
[TBL] [Abstract][Full Text] [Related]
6. Discordance rate of HER2 status in primary gastric carcinomas and synchronous lymph node metastases: a multicenter retrospective analysis.
Ieni A; Barresi V; Caltabiano R; Caleo A; Bonetti LR; Lanzafame S; Zeppa P; Caruso RA; Tuccari G
Int J Mol Sci; 2014 Dec; 15(12):22331-41. PubMed ID: 25479078
[TBL] [Abstract][Full Text] [Related]
7. Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma.
Bozzetti C; Negri FV; Lagrasta CA; Crafa P; Bassano C; Tamagnini I; Gardini G; Nizzoli R; Leonardi F; Gasparro D; Camisa R; Cavalli S; Silini EM; Ardizzoni A
Br J Cancer; 2011 Apr; 104(9):1372-6. PubMed ID: 21487407
[TBL] [Abstract][Full Text] [Related]
8. HER2 expression in primary gastric cancers and paired synchronous lymph node and liver metastases. A possible road to target HER2 with radionuclides.
Wei Q; Xu J; Shen L; Fu X; Zhang B; Zhou X; Carlsson J
Tumour Biol; 2014 Jul; 35(7):6319-26. PubMed ID: 24643685
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of HER2 gene status between primary breast cancer and synchronous axillary lymph node metastasis].
Liu YY; Wu SF; Liang ZY; Zeng X
Zhonghua Bing Li Xue Za Zhi; 2016 Jun; 45(6):393-6. PubMed ID: 27256047
[TBL] [Abstract][Full Text] [Related]
10. Variability in HER2 expression between primary colorectal cancer and corresponding metastases.
Shan L; Lv Y; Bai B; Huang X; Zhu H
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2275-2281. PubMed ID: 30203148
[TBL] [Abstract][Full Text] [Related]
11. Discordance Rate in Estrogen Receptor, Progesterone Receptor, HER2 Status, and Ki67 Index Between Primary Unifocal and Multiple Homogenous Breast Carcinomas and Synchronous Axillary Lymph Node Metastases Have an Impact on Therapeutic Decision.
Georgescu R; Boros M; Moncea D; Bauer O; Coros MF; Oprea A; Moldovan C; Podoleanu C; Stolnicu S
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):533-538. PubMed ID: 28099174
[TBL] [Abstract][Full Text] [Related]
12. Concordance of the HER2 protein and gene status between primary and corresponding lymph node metastatic sites of extramammary Paget disease.
Tanaka R; Sasajima Y; Tsuda H; Namikawa K; Takahashi A; Tsutsumida A; Fujisawa Y; Fujimoto M; Yamazaki N
Clin Exp Metastasis; 2016 Oct; 33(7):687-97. PubMed ID: 27289366
[TBL] [Abstract][Full Text] [Related]
13. Internodal HER2 heterogeneity of axillary lymph node metastases in breast cancer patients.
Baroš IV; Tanasković N; Pellas U; Eri Ž; Tadić Latinović L; Tot T
Bosn J Basic Med Sci; 2019 Aug; 19(3):242-248. PubMed ID: 30957723
[TBL] [Abstract][Full Text] [Related]
14. HER2 Status in Gastric Cancer: Comparison between Primary and Distant Metastatic Disease.
Amato M; Perrone G; Righi D; Pellegrini C; Rabitti C; Di Matteo F; Crucitti P; Caputo D; Coppola R; Tonini G; Santini D; Onetti Muda A
Pathol Oncol Res; 2017 Jan; 23(1):55-61. PubMed ID: 27363700
[TBL] [Abstract][Full Text] [Related]
15. EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: implications for targeted radiotherapy.
Shen L; Shui Y; Wang X; Sheng L; Yang Z; Xue D; Wei Q
BMC Cancer; 2008 Aug; 8():232. PubMed ID: 18700025
[TBL] [Abstract][Full Text] [Related]
16. Alterations in hormonal receptor expression and HER2 status between primary breast tumors and paired nodal metastases: discordance rates and prognosis.
Ba JL; Liu CG; Jin F
Asian Pac J Cancer Prev; 2014; 15(21):9233-9. PubMed ID: 25422206
[TBL] [Abstract][Full Text] [Related]
17. Human epidermal growth factor receptor-2 gene amplification in gastric cancer using tissue microarray technology.
Tsapralis D; Panayiotides I; Peros G; Liakakos T; Karamitopoulou E
World J Gastroenterol; 2012 Jan; 18(2):150-5. PubMed ID: 22253521
[TBL] [Abstract][Full Text] [Related]
18. The Case to Case Comparison of Hormone Receptors and HER2 Status between Primary Breast Cancer and Synchronous Axillary Lymph Node Metastasis.
Sujarittanakarn S; Himakhun W; Worasawate W; Prasert W
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1559-1565. PubMed ID: 32592349
[TBL] [Abstract][Full Text] [Related]
19. Immunoexpression of cyclooxygenase-2 in primary gastric carcinomas and lymph node metastases.
Almeida PR; Ferreira FV; Santos CC; Rocha-Filho FD; Feitosa RR; Falcão EA; Cavada BK; Lima-Júnior RC; Ribeiro RA
World J Gastroenterol; 2012 Feb; 18(8):778-84. PubMed ID: 22371637
[TBL] [Abstract][Full Text] [Related]
20. Comparison Between HER2, Estrogen Receptors and Progesterone Receptors in Primary Breast Carcinomas and Matched Lymph Node Metastases.
Desouki MM; Atta IS; Wolff DJ; Self SE
Turk Patoloji Derg; 2016; 32(3):178-85. PubMed ID: 27562392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
